Biogen enters $1.5B unsecured revolving credit facility, terminates prior facility

BIOGEN INC.

$1.5B five-year unsecured revolving credit facility; no borrowings drawn at closing.
Replaces 2020 credit agreement; no outstanding loans at termination.
Interest rates based on credit ratings: Term SOFR + 0.625%-1.375%; commitment fee 0.05%-0.15%.
Financial covenant: max consolidated leverage ratio of 3.75:1 (4.25:1 after material acquisition).
Matures August 2029, includes $25M letter of credit sublimit, $20M swing line.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.